HeartSciences Inc.
HSCS
$3.46
$0.113.28%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -54.29% | -19.13% | -50.10% | -13.10% | -22.48% |
| Total Depreciation and Amortization | 21.85% | 137.24% | 24.25% | -33.80% | 244.93% |
| Total Amortization of Deferred Charges | 431.40% | -20.39% | -- | -- | -- |
| Total Other Non-Cash Items | -72.48% | -81.30% | -71.24% | -28.78% | 13,173.33% |
| Change in Net Operating Assets | 203.10% | -157.88% | 77.54% | 109.22% | -323.40% |
| Cash from Operations | 22.89% | -120.97% | -43.75% | 17.47% | -105.98% |
| Capital Expenditure | 100.00% | 53.62% | -- | -542.11% | -151.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.14% | -155.10% | 83.67% | -- | -- |
| Cash from Investing | 68.09% | -190.00% | 83.67% | -1,342.11% | -1,305.71% |
| Total Debt Issued | -- | 453.65% | -- | -- | -- |
| Total Debt Repaid | -41.27% | 30.02% | 22.93% | 39.09% | 58.52% |
| Issuance of Common Stock | -97.26% | -56.73% | 54.01% | -73.77% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.03% | 269.55% | 70.07% | -76.41% | 7,611.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -120.86% | 39.50% | -35.32% | -369.06% | 709.29% |